<p>CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties</p>
DAUNORUBICIN IN ACUTE MYELOCYTIC LEUKqMIA
Daunorubicin
CIRCADIAN RHYTHM IN MURINE TOLERANCE OF DAUNORUBICIN
CARDIAC TOXICITY OF DAUNORUBICIN
Spectroscopic studies on the interaction of γ-cyclodextrin–daunorubicin inclusion complex with herring sperm DNA
D.A.T. (DAUNORUBICIN, CYTARABINE, 6-THIOGUANINE) IN ACUTE MYELOID LEUKÆMIA
Acute myeloid leukemia management and research in 2025
Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma
DAUNORUBICIN